Is Humana Inc. the Best Pharma Dividend Stock to Buy In 2024?
| HUM Etf | USD 282.63 6.83 2.48% |
About 55% of Humana's investors are presently thinking to get in. The analysis of overall sentiment of trading Humana Inc etf suggests that some investors are interested at this time. Humana's investing sentiment overview a quick insight into current market opportunities from investing in Humana Inc. Many technical investors use Humana Inc etf news signals to limit their universe of possible portfolio assets and to time the market correctly.
Humana etf news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Humana daily returns and investor perception about the current price of Humana Inc as well as its diversification or hedging effects on your existing portfolios.
Humana |
We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Humana Inc. stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower
Read at finance.yahoo.com
 |
Humana Fundamental Analysis
We analyze Humana's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Humana is currently under evaluation in retained earnings as compared to similar ETFs. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Humana Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Humana etf to make a market-neutral strategy. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics with similar companies.
Peers
Humana Related Equities
| MOH | Molina Healthcare | 1.28 | ||||
| CVS | CVS Health | 1.27 | ||||
| CI | Cigna Corp | 1.07 | ||||
| ALHC | Alignment Healthcare | 0.21 | ||||
| ELV | Elevance Health | 0.01 | ||||
| UNH | UnitedHealth Group | 0.16 | ||||
| CNC | Centene Corp | 0.99 |
Other Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.